These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1860 related items for PubMed ID: 17182231

  • 21. Hydrate modifications of the non-steroidal anti-inflammatory drug diclofenac sodium: Solid-state characterisation of a trihydrate form.
    Bartolomei M, Rodomonte A, Antoniella E, Minelli G, Bertocchi P.
    J Pharm Biomed Anal; 2007 Nov 05; 45(3):443-9. PubMed ID: 17709225
    [Abstract] [Full Text] [Related]

  • 22. Hyperbranched poly(esteramides) as solubility enhancers for poorly water-soluble drug glimepiride.
    Reven S, Grdadolnik J, Kristl J, Zagar E.
    Int J Pharm; 2010 Aug 30; 396(1-2):119-26. PubMed ID: 20600725
    [Abstract] [Full Text] [Related]

  • 23. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
    Yan YD, Sung JH, Kim KK, Kim DW, Kim JO, Lee BJ, Yong CS, Choi HG.
    Int J Pharm; 2012 Jan 17; 422(1-2):202-10. PubMed ID: 22085435
    [Abstract] [Full Text] [Related]

  • 24. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
    van Drooge DJ, Hinrichs WL, Visser MR, Frijlink HW.
    Int J Pharm; 2006 Mar 09; 310(1-2):220-9. PubMed ID: 16427226
    [Abstract] [Full Text] [Related]

  • 25. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.
    Ahuja N, Katare OP, Singh B.
    Eur J Pharm Biopharm; 2007 Jan 09; 65(1):26-38. PubMed ID: 16962750
    [Abstract] [Full Text] [Related]

  • 26. The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers.
    Al-Hamidi H, Obeidat WM, Nokhodchi A.
    Pharm Dev Technol; 2015 Jan 09; 20(1):74-83. PubMed ID: 24392858
    [Abstract] [Full Text] [Related]

  • 27. Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules.
    Karataş A, Bekmezci S.
    Acta Pol Pharm; 2013 Jan 09; 70(5):883-97. PubMed ID: 24147368
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels.
    Schver GCRM, Lee PI.
    Mol Pharm; 2018 May 07; 15(5):2017-2026. PubMed ID: 29601723
    [Abstract] [Full Text] [Related]

  • 30. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
    Ghanavati R, Taheri A, Homayouni A.
    Mater Sci Eng C Mater Biol Appl; 2017 Mar 01; 72():501-511. PubMed ID: 28024614
    [Abstract] [Full Text] [Related]

  • 31. Use of calcined Mg-Al-hydrotalcite to enhance the stability of celecoxib in the amorphous form.
    Ambrogi V, Perioli L, Marmottini F, Rossi C.
    Eur J Pharm Biopharm; 2007 May 01; 66(2):253-9. PubMed ID: 17123798
    [Abstract] [Full Text] [Related]

  • 32. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN, Vemavarapu C, Lodaya M.
    Int J Pharm; 2007 Jan 10; 328(2):119-29. PubMed ID: 16968659
    [Abstract] [Full Text] [Related]

  • 33. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP, Gaikwad NJ.
    Acta Pharm; 2009 Mar 10; 59(1):57-65. PubMed ID: 19304558
    [Abstract] [Full Text] [Related]

  • 34. Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix.
    Karavas E, Georgarakis M, Docoslis A, Bikiaris D.
    Int J Pharm; 2007 Aug 01; 340(1-2):76-83. PubMed ID: 17478064
    [Abstract] [Full Text] [Related]

  • 35. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V, Tajber L, Corrigan OI, Healy AM.
    Mol Pharm; 2011 Apr 04; 8(2):532-42. PubMed ID: 21323367
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method.
    Zajc N, Obreza A, Bele M, Srcic S.
    Int J Pharm; 2005 Mar 03; 291(1-2):51-8. PubMed ID: 15707731
    [Abstract] [Full Text] [Related]

  • 39. Preparation and physicochemical characterization of surfactant based solid dispersions of ezetimibe.
    Sancheti PP, Karekar P, Vyas VM, Shah M, Pore YV.
    Pharmazie; 2009 Apr 03; 64(4):227-31. PubMed ID: 19435139
    [Abstract] [Full Text] [Related]

  • 40. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS, Shimpi SL, Paradkar AR.
    Acta Pharm; 2007 Sep 03; 57(3):287-300. PubMed ID: 17878109
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 93.